Are you Dr. Kamat?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 68 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
6550 Fannin St
Ste 901
Houston, TX 77030Phone+1 713-441-1026Fax+1 713-799-9586
Summary
- Dr. Aparna (Wahekar) Kamat, MD is an obstetrician/gynecologist in Houston, Texas. She is currently licensed to practice medicine in Texas. She is affiliated with Houston Methodist Hospital, Texas Children's Hospital, and Houston Methodist Sugar Land Hospital.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 2004 - 2008
West Virginia UniversityResidency, Obstetrics and Gynecology, 1997 - 2001
Seth G.S. Medical CollegeClass of 1994
Certifications & Licensure
TX State Medical License 2002 - 2025- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Top Doctors:SE Texas Castle Connolly, 2013
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
- Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Start of enrollment: 2009 Mar 23
- Join now to see all
Publications & Presentations
PubMed
- Macrophage Checkpoint Nanoimmunotherapy Has the Potential to Reduce Malignant Progression in BioengineeredModels of Ovarian Cancer.Sabrina N VandenHeuvel, Eric Chau, Arpita Mohapatra, Sameera Dabbiru, Sanjana Roy
ACS Applied Bio Materials. 2024-12-16 - 3 citationsThe Proteolytic Landscape of Ovarian Cancer: Applications in Nanomedicine.Cailin O'Connell, Sabrina VandenHeuvel, Aparna Kamat, Shreya Raghavan, Biana Godin
International Journal of Molecular Sciences. 2022-09-01 - 2 citationsAuthor Correction: Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma.Premal H. Thaker, Liz Y. Han, Aparna A. Kamat, Jesusa M.G. Arevalo, Rie Takahashi
Nature Medicine. 2021-11-19
Press Mentions
The Case for Tumor and Germline Testing in Endometrial Cancer PatientsJune 27th, 2019
BAPS Hosts Inspiring Women’s ConferenceApril 18th, 2019
Professional Memberships
- Fellow
